Dld Asset Management, LP Intra Cellular Therapies, Inc. Call Options Transaction History

Dld Asset Management, LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $1.47 Million - $7.77 Million	-202,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$7.47 - $14.03 $7.1 Million - $13.3 Million	-950,900 Reduced 82.48%	202,000 $1.51 Million
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $3.73 Million - $5 Million	-350,200 Reduced 23.3%	1,152,900 $14.9 Million
Q1 2019 May 14, 2019	SELL	$10.9 - $14.09 $7.91 Million - $10.2 Million	-725,400 Reduced 32.55%	1,503,100 $18.3 Million
Q4 2018 Feb 13, 2019	BUY	$10.36 - $20.96 $9.33 Million - $18.9 Million	900,200 Added 67.77%	2,228,500 $25.4 Million
Q3 2018 Nov 13, 2018	BUY	$17.77 - $22.9 $3 Million - $3.87 Million	169,000 Added 14.58%	1,328,300 $28.8 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $2.4 Million - $3.24 Million	138,300 Added 13.55%	1,159,300 $20.5 Million
Q1 2018 May 14, 2018	BUY	$15.16 - $25.49 $9.07 Million - $15.3 Million	598,300 Added 141.54%	1,021,000 $21.5 Million
Q4 2017 Feb 12, 2018	BUY	$14.27 - $16.79 $6.03 Million - $7.1 Million	422,700	422,700 $6.12 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.21B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.